CSL Limited
CSL
주식 순위
#368
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
주가
$136.26
시가총액
$65.39B
변동 (1일)
-0.61%
변동 (1년)
-4.06%
국가
AU
거래 CSL Limited (CSL)
카테고리
Healthcare
CSL Limited (CSL)의 EPS
June 2026 기준 EPS TTM: $-5.29
CSL Limited의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 $-5.29입니다. 2024년 말에는 회사의 EPS가 $5.47였으며, 이는 2023년의 EPS $4.55와 증가입니다.
CSL Limited의 EPS 기록 (2000 ~ 2026)
매년 말의 EPS
| 연도 | EPS | 변화 |
|---|---|---|
| 2026 (TTM) | $-5.29 | -185.32% |
| 2025 | $6.20 | 13.35% |
| 2024 | $5.47 | 20.22% |
| 2023 | $4.55 | -31.37% |
| 2022 | $6.63 | 26.05% |
| 2021 | $5.26 | 13.61% |
| 2020 | $4.63 | 9.20% |
| 2019 | $4.24 | 50.89% |
| 2018 | $2.81 | -4.42% |
| 2017 | $2.94 | 9.29% |
| 2016 | $2.69 | -7.88% |
| 2015 | $2.92 | 8.15% |
| 2014 | $2.70 | 21.09% |
| 2013 | $2.23 | 12.45% |
| 2012 | $1.98 | -0.58% |
| 2011 | $1.99 | 49.05% |
| 2010 | $1.34 | 6.70% |
| 2009 | $1.25 | 7.16% |
| 2008 | $1.17 | 64.09% |
| 2007 | $0.71 | 500.34% |
| 2006 | $0.12 | -78.01% |
| 2005 | $0.54 | 168.22% |
| 2004 | $0.20 | 202.40% |
| 2003 | $0.07 | -21.18% |
| 2002 | $0.08 | -5.06% |
| 2001 | $0.09 | 83.13% |
| 2000 | $0.05 | 0.00% |
유사 기업 또는 경쟁사의 EPS
| 회사 | EPS | EPS 차이 | 국가 |
|---|---|---|---|
| $17.32 | -427.41% |
US
|
|
| $-7.98 | 50.85% |
US
|
|
| - | - |
CH
|
|
| $27.74 | -624.39% |
NL
|
|
| $13.70 | -358.98% |
BE
|
